Gujarat Themis Biosyn Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 449.44 million compared to INR 324.41 million a year ago. Revenue was INR 463.67 million compared to INR 335.74 million a year ago.

Net income was INR 177.7 million compared to INR 129.23 million a year ago. Basic earnings per share from continuing operations was INR 12.23 compared to INR 8.89 a year ago.